Early research (Phase 1)Study completedNCT01117623What this trial is testingContinuous Dosing of BAY73-4506 in Patients With Advanced MalignanciesWho this might be right forNeoplasm Bayer 86
Very early researchStudy completedNCT02042222What this trial is testingNovel Dose Escalation to Predict Treatment With HydroxyureaWho this might be right forSickle Cell Disease Baylor College of Medicine 70
Early research (Phase 1)Study completedNCT00824135What this trial is testingHaploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesWho this might be right forHematologic Malignancies St. Jude Children's Research Hospital 34
Early research (Phase 1)Study completedNCT02751918What this trial is testingPhase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant CancerWho this might be right forOvarian Neoplasms Bayer 65
Early research (Phase 1)Study completedNCT00124189What this trial is testingSafety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)Who this might be right forChronic Lymphoproliferative Diseases Geron Corporation 48
Early research (Phase 1)Looking for participantsNCT07061626What this trial is testingDetermine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade GliomaWho this might be right forEpendymomaHigh Grade Gliomas Cerenome 56
Early research (Phase 1)Ended earlyNCT02003573What this trial is testingVolasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)Who this might be right forLeukemia, Myeloid, Acute Boehringer Ingelheim 13
Early research (Phase 1)Ended earlyNCT00664586What this trial is testingContinuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid TumorsWho this might be right forRefractory Solid TumorsLymphoma Erimos Pharmaceuticals 21
Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Early research (Phase 1)Looking for participantsNCT07238075What this trial is testingADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic CancersWho this might be right forAdvanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors Adcytherix SAS 290
Early research (Phase 1)Temporarily pausedNCT07353229What this trial is testing68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk MeningiomaWho this might be right forHigh Risk MeningiomaRecurrent Meningioma Thomas Jefferson University 24
Early research (Phase 1)Study completedNCT02745743What this trial is testingPhase I Trial of BAY1251152 for Advanced Blood CancersWho this might be right forHematologic Neoplasms Bayer 21
Early research (Phase 1)Active Not RecruitingNCT05034497What this trial is testingIntraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesWho this might be right forLeptomeningeal Metastasis Cerenome 18
Early research (Phase 1)Ended earlyNCT01359618What this trial is testingDetermining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the HeartWho this might be right forHealthy Male AstraZeneca 16
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Ended earlyNCT03190967What this trial is testingT-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryWho this might be right forBreast CancerBrain MetastasisBrain Cancer National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00243087What this trial is testingInvestigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Who this might be right forLymphoma Boehringer Ingelheim 41
Testing effectiveness (Phase 2)Study completedNCT01893320What this trial is testingStudy of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeWho this might be right forLeukemia M.D. Anderson Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT03645395What this trial is testingPharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)Who this might be right forNon-hodgkin Lymphoma Molecular Templates, Inc. 9
Early research (Phase 1)Study completedNCT00676299What this trial is testingA Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.Who this might be right forProtein Kinase InhibitorsAntineoplastic ProtocolsClinical Trial, Phase 1+4 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 19